Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Jurre den Haan"'
Autor:
Ilse Bader, Colin Groot, H. Stevie Tan, Jean-Marie A. Milongo, Jurre den Haan, Inge M. W. Verberk, Keir Yong, Julie Orellina, Shannon Campbell, David Wilson, Argonde C. van Harten, Pauline H. B. Kok, Wiesje M. van der Flier, Yolande A. L. Pijnenburg, Frederik Barkhof, Elsmarieke van de Giessen, Charlotte E. Teunissen, Femke H. Bouwman, Rik Ossenkoppele
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-18 (2024)
Abstract Background Alzheimer’s disease (AD) is a common, complex and multifactorial disease that may require screening across multiple routes of referral to enable early detection and subsequent future implementation of tailored interventions. Blo
Externí odkaz:
https://doaj.org/article/80e39a0fdb1b42279ca2d571671cea81
Autor:
Frederique J. Hart de Ruyter, Tjado H. J. Morrema, Jurre den Haan, Gina Gase, Jos W. R. Twisk, Johannes F. de Boer, Philip Scheltens, Femke H. Bouwman, Frank D. Verbraak, Annemieke J. M. Rozemuller, Jeroen J. M. Hoozemans
Publikováno v:
npj Parkinson's Disease, Vol 9, Iss 1, Pp 1-9 (2023)
Abstract There is increasing interest in studying retinal biomarkers for various neurodegenerative diseases. Specific protein aggregates associated with neurodegenerative diseases are present in the retina and could be visualised in a non-invasive wa
Externí odkaz:
https://doaj.org/article/f133d6ba3b3b465b90db3046c23ce62f
Autor:
Jurre den Haan, Lajos Csinscik, Tom Parker, Ross W. Paterson, Catherine F. Slattery, Alexander Foulkes, Femke H. Bouwman, Frank D. Verbraak, Philip Scheltens, Tunde Peto, Imre Lengyel, Jonathan M. Schott, Sebastian J. Crutch, Timothy J. Shakespeare, Keir X. X. Yong
Publikováno v:
Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-9 (2019)
Abstract Background Retinal thickness can be measured non-invasively with optical coherence tomography (OCT) and may offer compelling potential as a biomarker for Alzheimer’s disease (AD). Retinal thinning is hypothesized to be a result of retrogra
Externí odkaz:
https://doaj.org/article/a174b48a2c1e46119b70577fd801cdb9
Autor:
Jurre den Haan, Tjado H. J. Morrema, Frank D. Verbraak, Johannes F. de Boer, Philip Scheltens, Annemieke J. Rozemuller, Arthur A. B. Bergen, Femke H. Bouwman, Jeroen J. Hoozemans
Publikováno v:
Acta Neuropathologica Communications, Vol 6, Iss 1, Pp 1-11 (2018)
Abstract In-vivo labeling of retinal amyloid-beta(Aβ) and tau has potential as non-invasive biomarker for Alzheimer’s disease (AD). However, literature on the presence of Aβ and phosphorylated tau (pTau) in AD retinas is inconclusive. We therefor
Externí odkaz:
https://doaj.org/article/a6c2a333201440bcb25ac3ea6f1c9e04
Autor:
Jurre den Haan, Tjado H. J. Morrema, Annemieke J. Rozemuller, Femke H. Bouwman, Jeroen J. M. Hoozemans
Publikováno v:
Acta Neuropathologica Communications, Vol 6, Iss 1, Pp 1-12 (2018)
Abstract The combined fluorescent and Aβ-binding properties of the dietary spice curcumin could yield diagnostic purpose in the search for a non-invasive Aβ-biomarker for Alzheimer’s disease (AD). However, evidence on the binding properties of cu
Externí odkaz:
https://doaj.org/article/75dd0001f4e54955828b760001c44bea
Autor:
Frederique J, Hart de Ruyter, Tjado H J, Morrema, Jurre, den Haan, Jos W R, Twisk, Johannes F, de Boer, Philip, Scheltens, Baayla D C, Boon, Dietmar R, Thal, Annemieke J, Rozemuller, Frank D, Verbraak, Femke H, Bouwman, Jeroen J M, Hoozemans
Publikováno v:
Acta neuropathologica.
The retina is a potential source of biomarkers for the detection of neurodegenerative diseases. Accumulation of phosphorylated tau (p-tau) in the brain is a pathological feature characteristic for Alzheimer's disease (AD) and primary tauopathies. In
Autor:
Peter J. Snyder, Jessica Alber, Stuart Sinoff, Delia Cabrera DeBuc, Jurre den Haan, Danielle Goldfarb, Kimberly A. Hernandez, Edmund Arthur, Francesca Cordeiro, Leonardo Provetti-Cunha, Louisa I. Thompson, Stephen Salloway, Gregory P. Van Stavern, Derrick L. Cheng
Publikováno v:
Alber, J, Goldfarb, D, Thompson, L I, Arthur, E, Hernandez, K, Cheng, D, DeBuc, D C, Cordeiro, F, Provetti-Cunha, L, den Haan, J, van Stavern, G P, Salloway, S P, Sinoff, S & Snyder, P J 2020, ' Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward ', Alzheimers & Dementia, vol. 16, no. 1, pp. 229-243 . https://doi.org/10.1002/alz.12006
The last decade has seen a substantial increase in research focused on the identification, development, and validation of diagnostic and prognostic retinal biomarkers for Alzheimer's disease (AD). Sensitive retinal biomarkers may be advantageous beca
Autor:
Jurre den Haan, Frederique Jasmine Hart de Ruyter, Ben Lochocki, Maurice A.G.M. Kroon, Marleen Kemper, Philip Scheltens, Frank Verbraak, Johannes de Boer, Femke H. Bouwman
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Jurre den Haan
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Benjamin Lochocki, E. Marleen Kemper, Charlotte E. Teunissen, Frederique Jasmine Hart de Ruyter, Frank D. Verbraak, Philip Scheltens, Bart N.M. van Berckel, Johannes F. de Boer, Jeroen J. M. Hoozemans, Maurice A.G.M. Kroon, Femke H. Bouwman, Aleid van de Kreeke, Jurre den Haan
INTRODUCTIONPrevious work showed the in-vivo presence of retinal amyloid in AD patients using curcumin. We aimed to replicate these findings in an amyloid biomarker confirmed cohort.METHODSTwenty-six AD patients (age 66 (+9), MMSE≥17) and 14 contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::943c4444aed5300823b7df44a7aa0b51
https://doi.org/10.1101/2021.10.07.21264420
https://doi.org/10.1101/2021.10.07.21264420